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Abstract
Leiomyosarcoma is a malignant mesenchymal tumor originating from smooth muscle cells, which
most frequently develops in the myometrium and in the gastro-intestinal tract. Reviewing the
international literature, radiation-induced sarcoma arise in 0.035 to 0.2 % of all irradiated patients.
Especially in the head and neck region, radiation-induced leiomyosarcoma is an extremely rare
lesion. The authors report a case of a radiation-induced leiomyosarcoma of the tonsillar region of
the oropharynx in a 51-year-old male patient, who had undergone radiation therapy of this region
38 years before. The lesion was treated by radical surgery. Diagnostic steps, histological
presentation and therapy are described in detail and the literature concerning radiation induced
malignancies in general as well as radiation induced leiomyosarcoma in particular is reviewed. The
highlights of this case are an extremely uncommon location and a rare pathological entity of
radiation induced malignancies.
Background
Leiomyosarcoma is a malignant mesenchymal tumor
which originates from smooth muscle cells and accounts
for about 7 to 9 % of all soft tissue sarcomas [1-3]. Leio-
myosarcomas most often arise in middle-aged persons,
but it is extremely rare in adolescents and children [1].
Sites of involvement are primarily the myometrium and
the gastro-intestinal tract, followed by the soft tissue of the
extremities and the retroperitoneum [1]. Leiomyosar-
coma of the head and neck is rare, as smooth muscle is sel-
dom encountered in this region, mainly in the walls of
blood vessels and the erector pili musculature of the skin
[8-10].
Radiation-associated sarcomas are uncommon, constitut-
ing less than 5 % of all sarcomas, and generally associated
with a poor prognosis [4]. Reviewing the international lit-
erature, radiation-induced sarcoma arise in 0.035 to 0.2 %
of all irradiated patients [4]. The most common histologic
subtypes of radiation-induced sarcomas are osteogenic,
malignant fibrous histiocytoma, angio- and lymphangi-
osarcoma as well as spindle cell sarcoma [4,5,7]. Radia-
tion-induced leiomyosarcoma is an uncommon
histological entity. Especially in the head and neck region,
this radiation-associated malignant neoplasm represents
an exceptional rarity [5-8].
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Case presentation
In March 2004 a 51-year-old male patient was referred to
our outpatient's department because of oropharyngeal
pain of the right tonsillar region. The complaints had
started one year before with a right sided feeling of pres-
sure in the oral cavity and the neck. In 1966, 38 years
before the patient presented to our department, he had
been treated for a squamous cell carcinoma of the left ton-
sil in the territory of the former Soviet Union. At that time,
the then 13-year-old boy underwent radical surgery fol-
lowed by adjuvant radiotherapy with a cumulative radia-
tion dose of 101 Gray. Although the patient was only 13
years old at the time when the diagnosis of a squamous
cell carcinoma of the left tonsil was made, the presented
documents left no doubt about the initial histological
diagnosis. When the 51-year-old patient presented to our
department in 2004, the otorhinolaryngological examina-
tion showed a smooth bounded neoformation in the
region of the right-sided tonsillar fossa and soft palate
with a diameter of about 2.5 cm (Fig. 1). The tumor's pal-
pation was dense. Computed tomography (CT) of the
oropharynx confirmed the neoformation to be smooth
bounded and well separated from the surrounding tissue
(Fig. 2). Computed tomography and ultrasonic examina-
tion of the neck did not reveal enlarged cervical lymph
nodes that might have indicated lymphogenic metastatic
spread. No indication for hematogenous metastatic
spread was found on plain x-rays of the chest, ultrasono-
graphic examination of the abdomen and positron emis-
sion tomography imaging studies.
An endoscopic examination of the larynx and hypophar-
ynx was performed in general anesthesia and revealed
these regions to be without pathological findings. Tumor-
resection was then carried out by a transoral approach in
combination with a mapping of the oropharyngeal
mucous membrane. Histological examination of the
tumor revealed spindle cells with marked polymorphism
implicating a storiform growthpattern (Fig. 3 a,b). Via
immunohistochemistry focal expression of α-actin and
S100 could be detected (Fig. 4a). The proliferation-index
was high (70 %) (Fig. 4b). Upon these morphologic and
immunohistochemical findings a leiomosacroma of the
oropharynx was diagnosed. The tumor was completely
removed by surgical resection and histological examina-
tion revealed the resection margins to be free of tumor
cells. Two months postoperatively an endoscopic control-
investigation with biopsy collection was carried out for
evaluation of microscopic tumor relapse. Histological
examination revealed marginal tumor-extension in the
region of the left-sided soft palate. Re-operation was car-
ried out by laser-surgery of the left-sided soft palate and
histological examination revealed no tumor-remnants to
be left in situ. The course of disease and treatment was
then supervised by clinical and radiological follow-up
Computed tomography (CT) of the oropharynx with con- trast medium Figure 2
Computed tomography (CT) of the oropharynx with 
contrast medium. The axial projection shows a smooth 
bounded nodular neoformation in the right-sided tonsil's 
region of the oropharynx. The other layers of the tomogra-
phy didn't reveal signs of enlarged cervical lymph nodes.
Intraoperative view of the oropharynx Figure 1
Intraoperative view of the oropharynx. A smooth 
bounded nodular tumor appears in the right-sided tonsil's 
region of the oropharynx. The neoformation expands on the 
anterior faucial pillar of the soft palate and the glosso-tonsil-
lar furrow.Diagnostic Pathology 2006, 1:22 http://www.diagnosticpathology.org/content/1/1/22
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control-investigations at regular 3 months intervals.
Unfortunately, a biopsy taken from the middle of the soft
palate in June 2005 again revealed microscopic signs of
tumor-relapse. At that time the patient was free of symp-
toms and did not show a clinical correlate of tumor-recur-
rence. Surgical resection of these findings had to be
performed two more times and histological investigations
finally revealed an R0-resection status. Up to now, the
patient did not undergo chemotherapy or radiotherapy of
the radiogenic-induced leiomyosarcoma. Close clinical
follow-up control-examinations with biopsies of the
former tumor region will now be performed. In case of
new tumor-relapse radical surgical resection and defect
reconstruction by a free radial forearm flap will be the
treatment of choice.
Discussion
Radiation therapy is a well accepted modality of treatment
in the therapeutical scheme of head and neck cancer. It is
of significance as an adjuvant method of treatment after
surgery and in some cases a valuable alternative to surgery
in cases where tumor-resection can not be performed or
would lead to limited quality of life from mutilation and
loss of function. Radiation-induced malignancy is a long-
term complication of radiation therapy. The potential of
ionizing radiation to induce malignant neoformations
was already observed in the early 20th century, only a short
time after Roentgen first discovered x-rays. The first cases
of radiation-induced skin cancers were reported by Frie-
ben et al. in 1908 [11]. Criteria for diagnosing malignancy
as radiation induced were firmly established by Cahan et
al. in 1948 and first described for radiation-induced sarco-
mas of long bones [12]. These criteria comprised, that 1.)
Immunohistochemistry of a tumor-biopsy Figure 4
Immunohistochemistry of a tumor-biopsy. Immunohis-
tochemical detection of a-actin, supporting the myogenic ori-
gin of the tumor (a, α-actin, 100×). The high proliferative 
activity is verified by MIB-1 (b, MIB-1, 100×).
A biopsy of the tumor in Hematoxilin-Eosin (HE) staining Figure 3
A biopsy of the tumor in Hematoxilin-Eosin (HE) 
staining. Spindle cell tumor with cellular polymorphism, 
mimicking a storiform growth pattern. Mitoses are also fre-
quent supporting a malignant proliferation. HE 100 × (a), 200 
× (b).Diagnostic Pathology 2006, 1:22 http://www.diagnosticpathology.org/content/1/1/22
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the patient had undergone radiation therapy, that 2.) the
radiation-induced malignancy arose in the previously
irradiated field, that 3.) there is histological evidence of a
sarcoma, that 4.) there is a latency period of at least 5 years
between radiation and the presentation of the radiation-
induced sarcoma and, to exclude tumor relapse, that 5.)
the proof, that primary and secondary tumor are of a dif-
ferent histological entity [4,6-8,12]. For almost 50 years
these criteria formulated by Cahan et al. were the guiding
principles for radiation-induced malignancies. Neverthe-
less, several small studies and case reports in the interna-
tional medical literature described radiation induced
malignancies originating from almost all kinds of tissue
with a latency period between 3 and 45 years [6,7]. Fur-
thermore, orthovoltage radiation, largely used prior to
1960, resulted in a much higher absorbed dose in bone
than in soft tissue and explained, that bone sarcomas
occurred with greater frequency than did soft-tissue sarco-
mas [4]. With the technological advance in radiation ther-
apy, this relation changed and thus, Cahans' criteria were
revised by Murray et al. in 1999 concerning the limita-
tions on the latency period and the histological entity of
radiation-induced neoformations [4,13]. Murray et al.
included soft tissue sarcomas as well as radiation-associ-
ated malignancies, that arose after a latency period of less
than five years, to fulfill the criteria for being radiation-
induced [6,13]. Although the median latency period in
studies reported in the international literature is 10 to 15
years, Brady et al. reported as much as 15 % of their
patients developed sarcomas less than 5 years after radia-
tion [4]. As the latency period appears to be inversely
related to age, especially a significant percentage of older
patients tend to have a latency period of less than 5 years
[4,13]. Data suggest, that there is no relationship between
cumulative radiation dose and the interval between expo-
sure to radiotherapy and the development of radiation-
induced sarcoma [5]. Surveying the international litera-
ture there are today no definitive criteria concerning the
histological tissue of origin for radiation-induced malig-
nant neoformations, but most data are still generated
from sarcomas [6]. Several mechanisms in which radia-
tion may induce genetic changes leading to malignant
transformation are under discussion, but the exact devel-
opment of radiation induced malignancy is still unclear.
The loss of heterozygosity in directly radiated cell nuclei
activate mutational occurrences in tumor suppressor
genes resulting in malignant degeneration. Furthermore,
genetic mutations may also be induced by cytoplasmatic
irradiation and the release of cytokines. Therefore, impor-
tant genetic effects can also be observed in cells, that did
not directly receive nuclear radiation [6,14].
With an estimated incidence of 0.4 to 1.0 % radiation
induced malignancy is a rare entitiy [6]. Radiation-associ-
ated sarcomas in particular are uncommon, constituting
less than 5 % of all sarcomas [4,7]. Brady et al. reported,
that the incidence of sarcomas that were associated with
radiation ranged from 1.5 to 3.9 % for any investigated
year [4]. According to his data, estimates of the incidence
of sarcoma occurring in patients who received radiother-
apy would suggest that radiation-induced sarcomas occur
in 0.035 to 0.2 % of patients who receive radiation ther-
apy [4]. These data are consistent with the information
given by Demirkan et al.: In his report the risk of develop-
ing radiation-induced soft tissue sarcoma for a cancer
patient who had to undergo radiotherapy and survives for
more than 5 years is 0.1 %. Patel et al. also numeralizes
the cumulative incidence of sarcoma after radiation ther-
apy ranges from 0.03 to 0.3 % [5,8,15,16]. Despite this
low incidence of radiation-induced sarcoma, this patho-
logical entity is today expected to be seen more frequently,
due to an increased life expectancy with progressive aging
of the population combined with improved survival in
cancer patients as a result of increased effectiveness of can-
cer therapy and better treatment regimes [5,8]. Neither a
minimum of cumulative radiation dose nor a correlation
between modality and form of radiation and the inci-
dence of radiation-induced sarcomas is reported in the
international medical literature [7]. A radiation dose-
response relationship was demonstrated for all sarcomas
and, for the first time in humans, for soft tissue sarcomas
in the studies by Wong et al. in 1997 [5,8,17].
Within the head and neck region, practically all types of
cancer have been reported after radiation therapy, but the
skin and the thyroid are the most commonly involved tis-
sues [5]. Squamous cell carcinoma is the most commonly
reported histological entity, but it has to be emphasized
that it is difficult to implicate therapeutic irradiation in
the causation of head and neck squamous cell carcinomas
because of the inherent risk of multiple primary tumors
and the role of tobacco and alcohol in the development of
head and neck carcinoma [5,18]. Although radiation-
induced sarcoma is a well-documented long-term compli-
cation of radiation therapy for other sites, the head and
neck is less commonly affected. Less than 1 % of all radi-
ation-induced sarcomas arise within the head and neck
region and thus is a rare entity with few reported series in
the international literature [4,5,7]. Nevertheless the regu-
lar appearance of case reports in medical literature reflects
the interest in these tumors as a long-term complication
of radiation therapy in the head and neck region. The
given details concerning the percentage of histological
subtypes of radiation induced sarcomas vary slightly
between the reported studies on topic. According to these
reports the most common histologic types of radiation-
induced sarcomas are considered to be osteogenic, malig-
nant fibrous histiocytoma, angio- and lymphangiosar-
coma as well as spindle cell sarcoma [4,5,7,8,19].Diagnostic Pathology 2006, 1:22 http://www.diagnosticpathology.org/content/1/1/22
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Leiomyosarcoma is a malignant spindle-cell mesenchy-
mal tumor originating from smooth muscle cells and con-
stituting about 7 to 9 % of all soft tissue sarcomas [1-
3,10,20]. Leiomyosarcoma most often arises in middle-
aged persons, but is extremely rare in adolescents and chil-
dren [1]. It most frequently develops in the myometrium
and in the gastro-intestinal tract, followed by the soft tis-
sue of the extremities and the retroperitoneum [1-3]. Lei-
omyosarcoma of the head and neck is rare, as smooth
muscle is seldom encountered in this region, mainly in
the walls of blood vessels and the erector pili musculature
of the skin [9,10,21-23]. Dry et al. in 1999 investigated lei-
omyosarcomas of the oral cavity and stated fewer than 50
cases reported in the English literature at the time of writ-
ing [9]. Leiomyosarcoma is not a lesion with a marked
propensity for dissemination and metastatic spread. If it
occurs, leiomyosarcoma like sarcoma in general typically
metastasizes via hematogenous routes to sites such as
lung, liver, bone and soft tissue [9,10,23]. According to
Dry et al. hematogenous spread can be found in 34 % of
the cases at the time of diagnosis [9]. Lymph node
involvement is reported to be extremely rare. Interest-
ingly, data presented by Dry et al. suggest, that leiomyosa-
rcoma of the oral cavity, unlike leiomyosarcomas in soft
tissue elsewhere, may occasionally metastasize to regional
lymphnodes [9]. Particularly because of their rarity, leio-
myosarcoma of the head and neck region may easily be
mistaken for other more common spindle cell lesions in
this location. Histologically, especially the tumors of the
neural sheath and malignant melanoma of spindle cell
type as well as spindle cell squamous carcinoma and spin-
dle cell myoepithelioma must be included in the differen-
tial diagnosis and may mimic leiomyosarcoma in
hematoxylin and eosin stained sections [9,10]. Also clini-
cally benign lesions that may occur in the head and neck
region like infantile and adult myofibroma and angiolei-
omyomas must be distinguished from leiomyosarcomas
as they histologically may present similar features [9].
Immunohistological examinations and careful histologi-
cal analysis are helpful adjuncts to distinguish between
these entities. By immunohistochemistry leiomyosar-
coma is positive for smooth muscle-specific α-actin [8-
10]. Diagnosis of leiomyosarcoma is established in com-
bination with the histological growth pattern of these
spindle cell tumors which are storiform alignment of the
spindle cells and marked polymorphism. A high prolifer-
ative activity is not uncommon.
In contrast to sarcomas of other histological subtypes, lei-
omyosarcomas are very rarely induced by radiotherapy
[4,5,7]. Especially in the head and neck region, this radia-
tion-associated histological entitiy is exceptionally
uncommon. Demirkan et al. in 2003 found 23 cases of
radiation-associated leiomyosarcomas reported in the
international literature [7]. Clinical diagnosis of radia-
tion-induced leiomyosarcoma can be difficult due to
induration and fibrosis of the tissue within the former
field of radiation [5]. Symptoms of leiomyosarcoma aris-
ing in the head and neck region are usually nonspecific.
The most significant symptoms of radiation-induced sar-
comas is the mass as well as the appearance of or the
change in the character of pain in the irradiated area [5].
According to most reported studies on radiation-induced
sarcomas complete surgical excision offers the only realis-
tic chance for long-term survival and also appears to
present the best means for palliation [4-8]. The response
to radiotherapy of leiomyosarcoma in general is poor,
especially when previous history of irradiation is taken
into account for radiation-induced leiomyosarcomas
[7,10,23]. Experience with adjuvant chemotherapy with
Ifosfamide, Doxorubicin, Cisplatin, Adriamycin and Vin-
blastin in the treatment of radiation-induced sarcoma is
limited but disappointing with the exception of the group
of young patients with osteosarcoma, who seem to
respond favourably to the treatment with methotrexat
[4,6]. As surgical excision of radiation-induced sarcoma of
the head and neck remains the only definitive treatment
option, early diagnosis and a correspondingly better
chance of complete surgical resection is essential for the
patient's prognosis. Widely variable latency periods of
radiation-induced sarcomas therefore necessitate lifelong
monitoring of the radiated field, especially in young
patients [6]. The prognosis of leiomyosarcoma arising
within the head and neck region is poor, even if they are
not associated with radiotherapy. It is reported that the
survival rates are better in the gastrointestinal tract and the
skin [10,23]. Radiation-induced sarcomas in particular
are generally associated with a poor prognosis. Data sug-
gest, that the overall five-year survival rate of radiation-
induced sarcoma ranges between 10 and 30 % [4-6,19].
Despite these tumors having traditionally been associated
with a poor prognosis, Brady et al. state, that the prognosis
of patients with soft-tissue radiation-induced sarcoma of
the extremities is similar to those of patients with sponta-
neous soft-tissue sarcoma of the extremities and that radi-
ation-induced sarcoma in general have similar prognostic
determinants to spontaneous sarcomas [4]. Thus, there is
no evidence, based on the data presented by Brady et al.
that patients with radiation-induced sarcomas should be
excluded from clinical trials based on a worse prognosis
[4]. The overall outlook concerning radiation-induced
sarcomas of the head and neck in particular has also been
reported to be very bleak [5-7]. The prognosis of radia-
tion-induced sarcoma of the head and neck region is gen-
erally perceived to be worse than spontaneous sarcomas
of the head and neck of similar stage and also appears to
be worse than the prognosis of radiation-induced soft-tis-
sue sarcoma and osteogenic sarcoma of similar stage in
other sites [5]. Although van der Laan et al. state that sur-
vival data after treatment of radiation-induced tumors isDiagnostic Pathology 2006, 1:22 http://www.diagnosticpathology.org/content/1/1/22
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not different from nonradiation-induced tumors in the
head and neck, most papers quote the poor outcome of
radiation-induced sarcoma of the head and neck with
reported five-year disease free survivals of less than 10 %
[5,24]. According to Patel et al. the poor prognosis of radi-
ation-induced sarcoma of the head and neck may be
explained on the basis of a delay in diagnosis due to a dif-
ficult clinical examination and nonspecific symptoms in
an irradiated tissue, the limits of surgical resection within
the head and neck region as well as limited treatment
options and a relatively poor sensitivity of these tumors to
chemotherapy [5].
We present here an additional case of radiation-induced
leiomyosarcoma of the head and neck. The presented case
fulfils all criteria for diagnosing the malignancy as radia-
tion induced, that were formulated by Cahan et al. in
1948 and that are described above [12]. The neoplasm
occurred as a long-term complication of cancer treatment
with a latency period of 38 years after radiation-therapy
with an excessive cumulative radiation dose of 101 Gray
in a young patient. Although squamous cell carcinoma of
the oropharynx is a rare lesion at the age of 13, the pre-
sented documents left no doubt about this histological
diagnosis of the primary tumor and tumor relapse of a lei-
omyosarcoma 38 years after treatment appears hardly
possible. Furthermore leiomyosarcoma is an extremely
uncommon neoplasm in adolescents and children [1].
While the primary squamous cell carcinoma arose in the
left tonsil, the presented radiation-induced sarcoma
became apparent in the right-sided oropharynx and was
successfully treated by radical surgery until now.
Conclusion
The presented case demonstrates, that clinicians manag-
ing cancer patients as well as pathologists have to be
aware of radiation-induced sarcomas as a long-term com-
plication of treatment, especially as this pathological
entity is today expected to be seen more frequently due to
an increased life expectancy combined with improved sur-
vival of cancer patients resulting from an increased effec-
tiveness of cancer therapy. As the prognosis of radiation-
induced malignancies in general is poor and the treatment
options are limited, early diagnosis and a correspondingly
better chance of complete surgical excision assume great
importance. Nevertheless it has to be emphasized, that the
incidence of radiation-induced malignancies is small
enough that the risk of its occurrence is vastly outweighed
by the benefits obtained from radiation therapy by most
patients.
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